Gelatin & collagen peptide maker for pharma capsules; JV of Kerala govt and Nitta Gelatin, Japan
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 144 | 164 | 192 | 259 | 334 | 413 | 443 | 502 |
| Borrowings | 84 | 80 | 86 | 39 | 14 | 31 | 21 | 4 |
| Other Liabilities | 57 | 53 | 58 | 60 | 65 | 62 | 68 | 71 |
| Total Liabilities | 294 | 306 | 345 | 367 | 423 | 515 | 541 | 586 |
| AssetsFixed Assets | 121 | 113 | 107 | 114 | 114 | 117 | 144 | 148 |
| CWIP | 4 | 2 | 7 | 7 | 8 | 19 | 5 | 15 |
| Investments | 1 | 1 | 1 | 1 | 1 | 7 | 8 | 8 |
| Other Assets | 169 | 191 | 230 | 246 | 300 | 372 | 385 | 415 |
| Total Assets | 294 | 306 | 345 | 367 | 423 | 515 | 541 | 586 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 22 | 40 | 19 | 17 | 101 | 94 | 75 | 122 |
| Cash from Investing | -14 | -10 | -7 | -14 | -18 | -54 | -9 | -182 |
| Cash from Financing | -7 | -33 | -12 | -2 | -55 | -36 | 11 | -37 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 5 | 30 | 11 | 2 | 82 | 78 | 52 | 72 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (9.0×) and current (14.7×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 9.4% growth and a 9× exit, ₹1577 only delivers your return if you pay ₹648. The price is currently baking in 28% growth.
EPS grows 9.4%/yr for 5 years, then fades to 6% over 2, exits at 9×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 9.4% | 117.18 |
| FY28 | 9.4% | 128.19 |
| FY29 | 9.4% | 140.24 |
| FY30 | 9.4% | 153.43 |
| FY31 | 9.4% | 167.85 |
| FY32 | 7.7% ·fade | 180.77 |
| FY33 | 6.0% ·fade | 191.62 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.